Wolverine Trading
CYCN icon

Wolverine Trading’s Cyclerion Therapeutics CYCN Stock Holding History

Wolverine Trading’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,400
Closed -$49.2K – 4603
2023
Q3 		$49.2K Sell
14,400
-19,100
-57% -$68.9K ﹤0.01% 4183
2023
Q2 		$147K Buy
33,500
+31,825
+1,900% +$165K ﹤0.01% 3640
2023
Q1 		$15K Sell
1,675
-630
-27% -$7.95K ﹤0.01% 4041
2022
Q4 		$30K Hold
2,305
– – ﹤0.01% 3679
2022
Q3 		$42K Hold
2,305
– – ﹤0.01% 4194
2022
Q2 		$25K Sell
2,305
-275
-11% -$3.94K ﹤0.01% 4202
2022
Q1 		$58K Sell
2,580
-40
-2% -$964 ﹤0.01% 5033
2021
Q4 		$84K Buy
2,620
+1,745
+199% +$82.4K ﹤0.01% 5153
2021
Q3 		$54K Buy
+875
New +$57.3K ﹤0.01% 6001

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's CYCN Position: Q1 2022 in Review

Wolverine Trading sold out of Cyclerion Therapeutics (CYCN) in Q1 2022, closing a stake of 898 shares — an estimated $21.6K sold.

Wolverine Trading first reported a position in CYCN in Q4 2021 and held it in 1 quarter. The position peaked at $29K in Q4 2021. 50 funds tracked by Wall St. Rank hold CYCN as of Q1 2022.

  • Wolverine Trading reported no remaining Cyclerion Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Wolverine Trading sold 898 Cyclerion Therapeutics shares in Q1 2022, an estimated $21.6K.
  • Wolverine Trading first reported a position in Cyclerion Therapeutics in Q4 2021 and held it in 1 quarter.
  • Wolverine Trading's Cyclerion Therapeutics position peaked at $29K in Q4 2021.
  • 50 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q1 2022.

Based on Wolverine Trading's 13F filing for Q1 2022, filed 16 May 2022.